Serum C-reactive protein to albumin ratio as a novel inflammation biomarker in psoriasis patients treated with adalimumab, ustekinumab, infliximab, and secukinumab: a retrospective study

---

Tamer F., Avci E.

CROATIAN MEDICAL JOURNAL, cilt.61, sa.4, ss.333-337, 2020 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 61 Sayı: 4
• Basım Tarihi: 2020
• Doi Numarası: 10.3325/cmj.2020.61.333
• Dergi Adı: CROATIAN MEDICAL JOURNAL
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Central & Eastern European Academic Source (CEEAS), EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
• Sayfa Sayıları: ss.333-337
• Gazi Üniversitesi Adresli: Evet

Özet

Aim To assess C-reactive protein to albumin ratio (CAR) be-fore and after treatment with biological agents in patients with psoriasis to determine whether CAR can be used as an inflammation biomarker.